Technology
Protein crystallization technique is traditionally used only for the determination of the three-dimensional structure of a protein. At ProCrysta, we have mastered the art of crystallization of macromolecule to make it beneficial in many ways for protein therapeutics...
...more   
Product R & D
ProCrysta is committed to bring breakthrough new treatments to patients with unmet medical needs. Infectious diseases are the second leading cause of deaths worldwide, after heart disease. Tuberculosis (TB), disease of the past, is still a devastating...
...more   
Applications
Advances in research and development, protein engineering, high specificity and protein production boosted the therapeutic applications of proteins and brought more than 140 biologics into the market. Over 90% of small molecule drugs...
...more   
 

ProCrysta Biologix, Inc. is dedicated to develop novel protein therapeutics for the treatment and prevention of infectious diseases and metabolic disorders through its proprietary crystallization technology.  The technology has potential to bring breakthrough new treatments to patients with unmet medical needs.

ProCrysta’s proprietary crystallization technology designs effective protein therapeutics with a choice of delivery options; oral, subcutaneous, topical or pulmonary routes.  As more biologics considered for therapy, high concentration and controlled release formulations become the key features for its successful development. ProCrysta's unparalleled technology can engender a unique opportunity for biologics formulation and delivery to improve the health and patient compliance.

ProCrysta is developing a novel protein therapy for the treatment of tuberculosis. This program is funded by NIH.

 
Home      |     Technology      |      Product R & D      |     Applications/Strategic Alliance      |     About Us      |     Contact
 
©2011 ProCrysta Biologix